LON:OPTI OptiBiotix Health - OPTI Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 11.25 0.00 (0.00%) (As of 03/21/2023 12:00 AM ET) Add Compare Share Share Today's Range 11.03▼ 11.3250-Day Range 11▼ 14.6952-Week Range 10.60▼ 41.15Volume44,468 shsAverage Volume82,545 shsMarket Capitalization£10.26 millionP/E Ratio187.50Dividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines About OptiBiotix Health (LON:OPTI) StockOptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.Read More Receive OPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OPTI Stock News HeadlinesFebruary 23, 2023 | lse.co.ukOptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiaryFebruary 18, 2023 | marketwatch.comHome Meal Replacement (HMR) Market 2023 : Global Industry Share, Key Dynamics and Forecast to 2028March 22, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. January 15, 2023 | marketwatch.comHome Meal Replacement (HMR) Market 2023 : Industry Analysis, Opportunities, Technology, Top Players and Growth Forecast 2028December 5, 2022 | marketwatch.comOptiBiotix Health Shares Fall on Discounted Fund RaisingOctober 24, 2022 | lse.co.ukOptiBiotix Health gets approval to sell products in Saudi ArabiaAugust 30, 2022 | nz.finance.yahoo.comPrebiotic Ingredients Market Size to Reach Around USD 20.78 Bn by 2030August 24, 2022 | lse.co.ukOptiBiotix shares plunge on "very difficult trading" in half-yearMarch 22, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. August 24, 2022 | marketwatch.comOptiBiotix Health Sees 1H Sales Below Expectations; Shares DiveAugust 23, 2022 | fool.co.ukOptiBiotix HealthJuly 18, 2022 | benzinga.comOptiBiotix Health (OTC:OPBXF), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comOptiBiotix Health (OTC:OPBXF), Analyst Ratings, Price Targets, PredictionsJuly 11, 2022 | marketwatch.comOptiBiotix Signs Selling, Manufacturing Joint Development Deal With FirmenichJune 28, 2022 | marketwatch.comOptiBiotix 2021 Pretax Profit Rose on Higher Revenue; Says Making Good Progress in 2022June 20, 2022 | lse.co.ukOptiBiotix welcomes Steen Anderson as new CEO of ProBiotix spin-offMay 31, 2022 | lse.co.ukLaunch of cholesterol reducing yoghurtApril 21, 2022 | msn.comPM Boris Johnson announces new deals worth £1bn on India visitMarch 31, 2022 | proactiveinvestors.comOptiBiotix Health CEO Stephen O’Hara explains why it makes sense to spin off ProBiotix HealthMarch 31, 2022 | proactiveinvestors.com.auOptiBiotix Health demerger complete as ProBiotix Health debuts on Aquis exchangeFebruary 28, 2022 | lse.co.ukTRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividendFebruary 28, 2022 | marketwatch.comOptiBiotix 2021 Sales, Gross Profit Rose as It Expanded to New RegionsFebruary 9, 2022 | marketwatch.comOptiBiotix Plans Territory, Product Line Expansions in 2022January 30, 2022 | proactiveinvestors.com.auFive at Five: Another FTSE 100 fall, rate rise coming, Optibiotix readies new generation of products, Biden turns on crypto and Tesla tanksJanuary 18, 2022 | proactiveinvestors.comOptiBiotix Health says latest study supports case for LPLDL as an alternative to statinsJanuary 11, 2022 | msn.comSMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentum with next gen microbiome-focused developmentsJanuary 11, 2022 | msn.comSMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentumSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OPTI Company Calendar Last Earnings9/24/2020Today3/21/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:OPTI Previous SymbolLON:CMI CUSIPN/A CIKN/A Webwww.optibiotix.com Phone+44-20-79338780FaxN/AEmployees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.06 Trailing P/E Ratio188.17 Forward P/E RatioN/A P/E GrowthN/ANet Income£5.91 million Net Margins470.44% Pretax MarginN/A Return on Equity24.67% Return on Assets-4.48% Debt Debt-to-Equity Ratio4.51 Current Ratio8.39 Quick Ratio7.89 Sales & Book Value Annual Sales£1.26 million Price / Sales8.14 Cash FlowGBX 1.30 per share Price / Cash Flow8.68 Book ValueGBX 25 per share Price / Book0.45Miscellaneous Outstanding Shares91,190,000Free FloatN/AMarket Cap£10.26 million OptionableNot Optionable Beta1.61 Key ExecutivesMr. Stephen Patrick O'HaraFounder, CEO & Exec. DirectorDr. Sofia Kolyda (Age 50)Exec. Director of R&D and Exec. Director Comp: $119.82kMr. Rene KammingaCEO of Functional Fibres & DirectorMr. Mark Kingsley Collingbourne (Age 57)CFO & Sec. Paul CanningsHead of Operations & QualityKevin James NewmanCorp. Devel. DirectorMr. Karl BurkittMarketing DirectorMore ExecutivesKey CompetitorsCizzle BiotechnologyLON:CIZIXICOLON:IXIValiRxLON:VALRoquefort TherapeuticsLON:ROQFusion AntibodiesLON:FABView All CompetitorsInsidersRené KammingaBought 2,656 shares on 3/24/2022Total: £100,928.00 ($38.00/share)View All Insider Transactions OPTI Stock - Frequently Asked Questions How have OPTI shares performed in 2023? OptiBiotix Health's stock was trading at GBX 13.25 on January 1st, 2023. Since then, OPTI stock has decreased by 15.1% and is now trading at GBX 11.25. View the best growth stocks for 2023 here. How were OptiBiotix Health's earnings last quarter? OptiBiotix Health Plc (LON:OPTI) posted its earnings results on Thursday, September, 24th. The company reported ($0.70) EPS for the quarter. OptiBiotix Health had a net margin of 470.44% and a trailing twelve-month return on equity of 24.67%. What other stocks do shareholders of OptiBiotix Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other OptiBiotix Health investors own include Digital Globe Services (DGS), Derwent London (DLN), Oracle (ORCL), IQE (IQE), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE), Petrofac (PFC), Motif Bio (MTFB), Yamana Gold (YRI) and Agios Pharmaceuticals (AGIO). What is OptiBiotix Health's stock symbol? OptiBiotix Health trades on the London Stock Exchange (LON) under the ticker symbol "OPTI." How do I buy shares of OptiBiotix Health? Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is OptiBiotix Health's stock price today? One share of OPTI stock can currently be purchased for approximately GBX 11.25. How much money does OptiBiotix Health make? OptiBiotix Health (LON:OPTI) has a market capitalization of £10.26 million and generates £1.26 million in revenue each year. The company earns £5.91 million in net income (profit) each year or GBX 0.06 on an earnings per share basis. How can I contact OptiBiotix Health? OptiBiotix Health's mailing address is Innovation Centre, Innovation Way, HESLINGTON, YO10 5DG, United Kingdom. The official website for the company is www.optibiotix.com. The company can be reached via phone at +44-20-79338780. This page (LON:OPTI) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.